SOPHiA GENETICS SA reaffirmed revenue guidance for the year 2022. The company expects full year revenue for 2022 to be in the range of $51.5 million to $54 million, representing growth of 27% to 33% over full year revenue for 2021.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.775 USD | -0.52% | +5.26% | +1.91% |
07-04 | Dhiti Omics Is Now Live on SOPHiA DDM | CI |
06-27 | Guggenheim Initiates SOPHiA GENETICS at Buy With $6 Price Target | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.91% | 314M | |
+19.54% | 3,341B | |
+19.05% | 93.92B | |
+14.45% | 85.47B | |
+66.98% | 63.85B | |
+40.29% | 49.38B | |
-23.14% | 48.74B | |
-22.99% | 47.68B | |
+75.85% | 40.9B | |
-4.26% | 26.97B |
- Stock Market
- Equities
- SOPH Stock
- News SOPHiA GENETICS SA
- SOPHiA GENETICS SA Reaffirms Revenue Guidance for the Year 2022